Basic Study
Copyright ©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 105173
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105173
Figure 7
Figure 7 High glucose promotes epidermal growth factor receptor expression by reducing ERRFI1 stability. A: Detection of the ubiquitination level of ERRFI1; B: ERRFI1 expression detected by Western blotting; C: ERRFI1 stability detected by cycloheximide chase; D: Binding between ERRFI1 and epidermal growth factor receptor (EGFR) detected by coimmunoprecipitation; E: Western blot showing ERRFI1 knockdown efficiency; F: Western blot showing EGFR expression. aP < 0.05. bP < 0.01. cP < 0.001. IP: Immunoprecipitation; IB: Immunoblotting; NC: Normal control; HG: High glucose; CHX: Cycloheximide; NC: Normal control; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; sh-NC: Short hairpin-negative control; sh-ERRFI1: Short hairpin RNA targeting ERRFI1; EGFR: Epidermal growth factor receptor.